Shedir Pharma Group Logo

Shedir Pharma Group

Researches, develops, and commercializes health and wellness products.

SHE | XMIL

Overview

Corporate Details

ISIN(s):
IT0005379620
LEI:
81560092B300849E9017
Country:
Italy
Address:
VIA BAGNULO, 95, 80063 PIANO DI SORRENTO

Description

Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-01-23 15:09
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 165.5 KB
2025-01-13 17:33
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 182.0 KB
2025-01-10 18:00
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 159.1 KB
2025-01-09 19:17
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 147.6 KB
2025-01-07 18:45
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 150.6 KB
2025-01-03 17:36
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 156.6 KB
2024-12-27 17:49
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 156.4 KB
2024-12-20 17:49
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 156.6 KB
2024-12-13 17:42
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 157.4 KB
2024-12-06 17:49
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 137.0 KB
2024-11-29 18:20
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 340.2 KB
2024-11-29 18:18
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 127.5 KB
2024-11-29 18:16
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 1.1 MB
2024-09-26 18:01
SHEDIR PHARMA GROUP - AL 30 GIUGNO 2024 FATTURATO ED EBITDA CONSOLIDATI IN AUME…
Italian 769.4 KB
2024-09-02 17:56
Dymalife finalizza l'acquisizione di un Ramo d'Azienda
Italian 377.0 KB

Automate Your Workflow. Get a real-time feed of all Shedir Pharma Group filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Shedir Pharma Group

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Shedir Pharma Group via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.